בוטומידור 10 מג מל וטרינרי

Country: Israel

Bahasa: Ibrani

Sumber: Ministry of Health

Bahan aktif:

BUTORPHANOL AS TARTRATE

Boleh didapati daripada:

VETMARKET LTD, ISRAEL

Borang farmaseutikal:

תמיסה להזרקה

Komposisi:

BUTORPHANOL AS TARTRATE 10 MG/ML

Laluan pentadbiran:

תת-עורי, תוך-שרירי, תוך-ורידי

Jenis preskripsi:

מרשם נדרש

Dikeluarkan oleh:

RICHTER PHARMA AG, AUSTRIA

Tarikh kebenaran:

2020-05-31

Risalah maklumat

1
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
BUTOMIDOR 10 MG/ML VETERINARY
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
1 ml contains:
ACTIVE SUBSTANCE:
Butorphanol 10 mg
(as butorphanol tartrate 14.58 mg)
EXCIPIENT:
Benzethonium chloride
0.1 mg
For the full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Solution for injection.
Clear, colourless to almost colourless solution.
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Horse, dog, cat
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
HORSE
AS AN ANALGESIC
For the short term relief of pain such as colic of gastrointestinal
tract origin.
AS A SEDATIVE AND PRE-ANAESTHETIC
In combination with
α
2
-adrenoceptor agonists (detomidine, xylazine):For therapeutic and
diagnostic
procedures such as minor standing surgery and sedation of intractable
patients.
DOG/CAT
AS AN ANALGESIC
For relief of moderate visceral pain e.g. pre- and post-surgical as
well as post-traumatic pain.
AS A SEDATIVE
In combination with

2
-adrenoceptor agonists (medetomidine).
AS A PRE-ANAESTHETIC
Part of anaesthetic regime (medetomidine, ketamine).
2
4.3
CONTRAINDICATIONS
Do not use in cases of hypersensitivity to the active substance or to
any of the excipients. Do not use
for treatment of animals with severe dysfunction of the liver and
kidneys, in case of cerebral injury or
organic brain lesions and in animals with obstructive respiratory
diseases, heart dysfunctions or
spastic conditions.
For combination use with

2
-agonists in horses:
Do not use in horses with a pre-existing cardiac dysrhythmia or
bradycardia.
The combination will cause a reduction in gastrointestinal motility
and consequently should not be
used in cases of colic associated with impaction.
Do not use combination during pregnancy.
4.4
SPECIAL WARNINGS FOR EACH TARGET SPECIES
The precautionary measures required for contact with animals should be
followed and stress factors
for the animals should be avoided.
In cats, individual response to butorphanol may be variable. In the
absence of an adequate analgesi